A retrospective study for prognostic significance of type II diabetes mellitus and hemoglobin A1c levels in non-small cell lung cancer patients treated with pembrolizumab

BACKGROUND: Diabetes mellitus (DM) is common and recognized as a risk factor for developing non-small cell lung cancer (NSCLC) while the prognostic evaluation is still controversial. As immunotherapy is widely used in clinical practice, its efficacy and survival should be investigated in patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Yinchen, Li, Jiaqi, Qiang, Huiping, Lei, Yuqiong, Chang, Qing, Zhong, Runbo, Stella, Giulia Maria, Gelsomino, Francesco, Kim, Yeon Wook, Abed, Afaf, Qian, Jialin, Chu, Tianqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459606/
https://www.ncbi.nlm.nih.gov/pubmed/36090639
http://dx.doi.org/10.21037/tlcr-22-493

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459606/
https://www.ncbi.nlm.nih.gov/pubmed/36090639
http://dx.doi.org/10.21037/tlcr-22-493

Ejemplares similares